A detailed history of Sector Gamma As transactions in Incyte Corp stock. As of the latest transaction made, Sector Gamma As holds 203,376 shares of INCY stock, worth $15 Million. This represents 4.81% of its overall portfolio holdings.

Number of Shares
203,376
Previous 264,895 23.22%
Holding current value
$15 Million
Previous $15.1 Million 18.31%
% of portfolio
4.81%
Previous 4.45%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$51.18 - $63.75 $3.15 Million - $3.92 Million
-61,519 Reduced 23.22%
203,376 $12.3 Million
Q1 2024

May 08, 2024

SELL
$56.55 - $66.59 $7.57 Million - $8.91 Million
-133,804 Reduced 33.56%
264,895 $15.1 Million
Q4 2023

Feb 05, 2024

SELL
$52.16 - $64.19 $1.77 Million - $2.17 Million
-33,846 Reduced 7.82%
398,699 $25 Million
Q3 2023

Nov 06, 2023

BUY
$57.77 - $65.93 $2.02 Million - $2.31 Million
35,013 Added 8.81%
432,545 $25 Million
Q2 2023

Aug 09, 2023

SELL
$60.95 - $75.51 $2.12 Million - $2.62 Million
-34,703 Reduced 8.03%
397,532 $24.7 Million
Q1 2023

May 12, 2023

BUY
$70.23 - $86.01 $1.46 Million - $1.78 Million
20,748 Added 5.04%
432,235 $31.2 Million
Q4 2022

Feb 07, 2023

SELL
$67.18 - $84.11 $490,884 - $614,591
-7,307 Reduced 1.74%
411,487 $33.1 Million
Q3 2022

Nov 09, 2022

SELL
$66.18 - $82.86 $2.69 Million - $3.37 Million
-40,635 Reduced 8.84%
418,794 $27.9 Million
Q2 2022

Aug 05, 2022

BUY
$66.18 - $83.18 $1.15 Million - $1.45 Million
17,417 Added 3.94%
459,429 $34.9 Million
Q1 2022

May 06, 2022

BUY
$66.02 - $79.71 $4.17 Million - $5.03 Million
63,160 Added 16.67%
442,012 $35.1 Million
Q4 2021

Feb 08, 2022

BUY
$63.34 - $74.11 $4.82 Million - $5.64 Million
76,113 Added 25.14%
378,852 $27.8 Million
Q3 2021

Oct 29, 2021

BUY
$68.67 - $84.02 $1.28 Million - $1.56 Million
18,594 Added 6.54%
302,739 $20.8 Million
Q2 2021

Aug 04, 2021

SELL
$79.87 - $87.53 $4.55 Million - $4.98 Million
-56,906 Reduced 16.69%
284,145 $23.9 Million
Q1 2021

May 10, 2021

SELL
$76.02 - $100.5 $804,139 - $1.06 Million
-10,578 Reduced 3.01%
341,051 $27.7 Million
Q4 2020

Feb 10, 2021

BUY
$80.74 - $97.7 $5.39 Million - $6.52 Million
66,725 Added 23.42%
351,629 $30.6 Million
Q3 2020

Nov 09, 2020

BUY
$85.07 - $109.69 $758,569 - $978,105
8,917 Added 3.23%
284,904 $25.6 Million
Q2 2020

Aug 07, 2020

SELL
$74.18 - $108.93 $13.1 Million - $19.2 Million
-176,596 Reduced 39.02%
275,987 $28.7 Million
Q1 2020

May 11, 2020

BUY
$63.18 - $85.97 $10.7 Million - $14.6 Million
170,041 Added 60.18%
452,583 $33.1 Million
Q4 2019

Feb 12, 2020

SELL
$73.04 - $95.72 $4.63 Million - $6.06 Million
-63,351 Reduced 18.32%
282,542 $24.7 Million
Q3 2019

Nov 05, 2019

BUY
$72.82 - $86.52 $2.33 Million - $2.77 Million
32,000 Added 10.19%
345,893 $25.7 Million
Q2 2019

Jul 31, 2019

BUY
$73.52 - $88.7 $3.87 Million - $4.67 Million
52,600 Added 20.13%
313,893 $26.7 Million
Q1 2019

May 13, 2019

SELL
$63.56 - $88.17 $4.78 Million - $6.63 Million
-75,151 Reduced 22.34%
261,293 $22.5 Million
Q4 2018

Feb 12, 2019

BUY
$58.5 - $69.94 $7.18 Million - $8.58 Million
122,680 Added 57.39%
336,444 $21.4 Million
Q3 2018

Nov 15, 2018

BUY
$61.75 - $74.23 $5.77 Million - $6.94 Million
93,507 Added 77.76%
213,764 $14.8 Million
Q3 2018

Nov 08, 2018

BUY
$61.75 - $74.23 $7.43 Million - $8.93 Million
120,257 New
120,257 $8.31 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Sector Gamma As Portfolio

Follow Sector Gamma As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.